Evidence map›Paper›PMID 36128411›Full record

ArticleOpen forum infectious diseases2022

Standardization of Epidemiological Surveillance of Acute Poststreptococcal Glomerulonephritis

Kate M Miller, Chris Van Beneden, Malcolm McDonald, Thel K Hla, William Wong, Helen Pedgrift, David C Kaslow, Thomas Cherian, Jonathan R Carapetis, Amy Scheel and 5 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Open forum infectious diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 10 institutions in 5 countries.

Kate M MillerWesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Nedlands, Western Australia, Australia.ORCID https://orcid.org/0000-0002-1142-7697
Chris Van BenedenCDC Foundation, Atlanta, Georgia, USA.ORCID https://orcid.org/0000-0002-6250-9238
Malcolm McDonaldJames Cook University, Cairns, Queensland, Australia.
Thel K HlaWesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Nedlands, Western Australia, Australia.
William WongStarship Children's Hospital, Auckland, New Zealand.
Helen PedgriftQueensland Health, Cairns, Queensland, Australia.
David C KaslowPATH, Seattle, Washington, USA.
Thomas CherianMMGH Consulting GmBH, Geneva, Switzerland.
Jonathan R CarapetisWesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Nedlands, Western Australia, Australia.ORCID https://orcid.org/0000-0002-1182-9792
Amy ScheelEmory University School of Medicine, Atlanta, Georgia, USA.
Anna SealeLondon School of Hygiene & Tropical Medicine, London, United Kingdom.
Asha C BowenWesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Nedlands, Western Australia, Australia.ORCID https://orcid.org/0000-0002-3242-1155
Hannah C MooreWesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Nedlands, Western Australia, Australia.
Theresa LamagniUK Health Security Agency, London, United Kingdom.ORCID https://orcid.org/0000-0002-3965-8323
Bernardo Rodriguez-IturbeInstituto Nacional de Ciencias Medicas y Nutrición "Salvador Zubirán", Mexico City, Mexico.
The Kids Research Institute Australia · AUCDC Foundation · USEmory University · USInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán · MXJames Cook University · AUProgram for Appropriate Technology in Health · USQueensland Health · AUStarship Children's Health · NZUK Health Security Agency · GBUniversity of Warwick · GB

Funding

Wellcome Trust 205184/Z/16/Z
6 · The paper itself

Abstract

Acute poststreptococcal glomerulonephritis (APSGN) is an immune complex-induced glomerulonephritis that develops as a sequela of streptococcal infections. This article provides guidelines for the surveillance of APSGN due to group A

Indexed as

epidemiologyglomerulonephritisinfectious diseaseStreptococcus pyogenessurveillance

Identifiers

PMID36128411
PMCPMC9474944
OpenAlexW4296130425

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.